Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Simoons

Showing results (211-220 of 338) with videos related to

Pageof 34
Sort By:
British Heart Journal|February 1, 1985
Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplastyW Wijns, P W Serruys, M L Simoons, et al.
European Heart Journal|July 20, 2000
Prospective study of early discharge after acute myocardial infarction (SHORT)M J van der Vlugt, H Boersma, C M Leenders, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 1998
Fatty acid-binding protein and the early detection of acute myocardial infarctionJ F Glatz, G J van der Vusse, M L Simoons, et al.
European Heart Journal|April 1, 1984
Ventricular free wall rupture: sudden, subacute, slow, sealed and stabilized varietiesK Balakumaran, C J Verbaan, C E Essed, et al.
European Heart Journal|March 1, 1993
Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography? European Cooperative Study GroupA E Arnold, M L Simoons, J M Detry, et al.
European Heart Journal|September 3, 2004
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACSJ P Ottervanger, P Armstrong, E S Barnathan, et al.
Cardiovascular Drugs and Therapy|October 4, 2022
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS TrialsS P Radhoe, E Boersma, M Bertrand, et al.
European Heart Journal|May 23, 1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromesE Braunwald, A Maseri, P W Armstrong, et al.
Transplantation Proceedings|February 1, 1989
Cytoimmunological monitoring to detect rejection after heart transplantationN H Jutte, R Daane, J M van den Bemd, et al.
European Heart Journal|May 18, 1999
Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarctionA C Maas, R T van Domburg, J W Deckers, et al.
Pageof 34

Showing results (211-220 of 338) with videos related to

Sort By:
Pageof 34
British Heart Journal|February 1, 1985
Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplastyW Wijns, P W Serruys, M L Simoons, et al.
European Heart Journal|July 20, 2000
Prospective study of early discharge after acute myocardial infarction (SHORT)M J van der Vlugt, H Boersma, C M Leenders, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 1998
Fatty acid-binding protein and the early detection of acute myocardial infarctionJ F Glatz, G J van der Vusse, M L Simoons, et al.
European Heart Journal|April 1, 1984
Ventricular free wall rupture: sudden, subacute, slow, sealed and stabilized varietiesK Balakumaran, C J Verbaan, C E Essed, et al.
European Heart Journal|March 1, 1993
Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography? European Cooperative Study GroupA E Arnold, M L Simoons, J M Detry, et al.
European Heart Journal|September 3, 2004
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACSJ P Ottervanger, P Armstrong, E S Barnathan, et al.
Cardiovascular Drugs and Therapy|October 4, 2022
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS TrialsS P Radhoe, E Boersma, M Bertrand, et al.
European Heart Journal|May 23, 1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromesE Braunwald, A Maseri, P W Armstrong, et al.
Transplantation Proceedings|February 1, 1989
Cytoimmunological monitoring to detect rejection after heart transplantationN H Jutte, R Daane, J M van den Bemd, et al.
European Heart Journal|May 18, 1999
Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarctionA C Maas, R T van Domburg, J W Deckers, et al.
Pageof 34